Harmony Biosciences
- Market cap
- 2.29B
- P/E (TTM)i
- 12.73
- P/Bi
- 2.29
- EPSi
- 2.71
- Div yieldi
- 0.00%
- 52W posi
- 77%
Anonymous reader poll. Unscientific, not investment advice.
Harmony Biosciences shares were changing hands at 39.34, down 0.05% on the day. Its market capitalisation is about 2.29B, the #2681 most valuable US-listed company we track. Trading at a P/E of 12.74, the stock is 35% below its own five-year norm of 19.63. The 7 analysts covering the stock are, on balance, at Buy, targeting an average of 46.43 (+18%). Against a 52-week band of 25.52-43.49, the shares are currently 77% of the way up.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 18% of the universe, above its 200-day average.
- Signal has read BUY for 1 week.
- Its last 5 Buy calls have actually lost 11% on average three months out - the strategy's edge here has come from the basket, not from this ticker.
- Recent price momentum is +24.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 7.9% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 39.36
- Open
- 39.27
- Day range
- 39.10 - 39.86
- Avg price
- 39.45
- Volume
- 547.00K
- Turnover
- 21.58M
- Turnover ratei
- 1.05%
- Volume ratioi
- 0.65
- Amplitudei
- 1.94%
- 52-week rangei
- 25.52 - 43.49
Valuation
- P/Ei
- 14.52
- P/E (TTM)i
- 12.73
- P/Bi
- 2.29
- EPSi
- 2.71
- Book value / shi
- 17.16
- Net profit
- 157.82M
- Net assets
- 999.22M
Share structure
- Market cap
- 2.29B
- Float capi
- 2.05B
- Shares out
- 58.24M
- Float sharesi
- 52.10M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2020-08-19
9.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-13.49M net over the window
Short interest
- Shares short
- 4.63M
- % of floati
- 7.95%
- Days to coveri
- 4.34
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Harmony Biosciences (HRMY)?
Harmony Biosciences last traded at 39.34. The quote on this page refreshes every few seconds while US markets are open.
What is Harmony Biosciences's market cap?
About 2.29B.
What is the P/E ratio of Harmony Biosciences?
The trailing twelve-month P/E is 12.73, below its own 5-year average of 19.63 — in the middle of its historical range (38.60% percentile). See the Valuation tab for the full history.
Does Harmony Biosciences pay a dividend?
Harmony Biosciences does not currently pay a regular dividend.
Is Harmony Biosciences a buy according to analysts?
The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 46.43, which implies 18.0% upside from the current price. This is not investment advice.
What is Harmony Biosciences's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Harmony Biosciences a B (Buy). Twelve-month momentum in the top 18% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 03:12:05 · For reference only, not investment advice and not tailored to your situation.